Multiple Sclerosis Centers News Today

Young MS patients are at risk of irreversible disability accrual

In addition to medication management, pharmacists are educating patients and helping them navigate the complex medical system.

/PRNewswire/ -- ImmPACT Bio USA Inc. (ImmPACT Bio), a clinical-stage biopharmaceutical company developing a new generation of cellular therapies that have the...

NEW YORK, May 6, 2024 /PRNewswire/ -- Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and...

New guidance published for using neurofilament light to help manage MS

The leading research and educational conference for multiple sclerosis healthcare professionals in North America, the Consortium of Multiple Sclerosis Centers (CMSC) 38th Annual Meeting, returns to Nashville, Tennessee, May 29-June 1, 2024 at the Music City Center.

-- Lovell is an approved supplier to the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD) --

Phase 2 data published in NEJM show potential of frexalimab as high-efficacy therapy in relapsing MSHigh-dose frexalimab significantly reduced dis...

The term ‘smoldering MS’ has the blogger Trevis Gleason reflecting on the words used to discuss MS and the meanings they carry.

Results showed that evobrutinib did not produce a more superior reduction in annualized relapse rates than teriflunomide, a previously approved disease-modifying agent.